VTP50469

CAS No. 2169916-18-9

VTP50469 ( —— )

Catalog No. M23981 CAS No. 2169916-18-9

VTP50469 is a highly selective and orally active inhibitor of Menin-MLL interaction( Ki: 104 pM) and has potently anti-leukemia activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 337 In Stock
10MG 537 In Stock
25MG 868 In Stock
50MG 1161 In Stock
100MG 1584 In Stock
200MG 2133 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    VTP50469
  • Note
    Research use only, not for human use.
  • Brief Description
    VTP50469 is a highly selective and orally active inhibitor of Menin-MLL interaction( Ki: 104 pM) and has potently anti-leukemia activity.
  • Description
    VTP50469 is a highly selective and orally active inhibitor of Menin-MLL interaction( Ki: 104 pM) and has potently anti-leukemia activity.
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Apoptosis;Menin-MLL interaction
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2169916-18-9
  • Formula Weight
    630.8
  • Molecular Formula
    C32H47FN6O4S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:125 mg/mL (198.15 mM; Need ultrasonic)
  • SMILES
    CC(C)N(C(C)C)C(=O)C1=C(C=CC(=C1)F)OC2=CN=CN=C2N3CC4(C3)CCN(CC4)CC5CCC(CC5)NS(=O)(=O)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Krivtsov AV, et al. A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia. Cancer Cell. 2019 Dec 9;36(6):660-673.e11.
molnova catalog
related products
  • AFMK

    AFMK is an active metabolite of Melatonin with antioxidant and free radical scavenging activity. AFMK is a modulator of apoptosis and improves the anti-tumor effect of Gemcitabine in PANC-1 cells.

  • Manganese chloride

    Manganese chloride inhibits proliferation in a dose- and time-dependent manner induces G0/G1 and S phase arrest and apoptosis in A549 cells.

  • Polygalacin D

    Polygalacin D shows anti- proliferation, anti-inflammary, and hepatoprotective activities.